Back to search

Article

Plant-Based Virus-Like Particle (VLP) Vaccines Against Influenza and Hepatitis Viruses

2026-08-24

Abstract excerpt

Influenza viruses constantly evolve due to sporadic antigenic shifts and point mutations, which undermine vaccine effectiveness. Newly drifted pathogenic variants make current vaccines inadequate against circulating strains, requiring frequent updates to vaccine formulations. On the other hand, hepatitis viruses such as HAV, HBV, and HCV can cause acute and chronic infection of the liver, leading to liver cirrhosi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
25e130fe-f8c0-5c7e-9567-4aef45d5fa88
DOI
10.20944/preprints202608.1639.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Plant-Based Virus-Like Particle (VLP) Vaccines Against Influenza and Hepatitis VirusesDOI 10.20944/preprints202608.1639.v1
The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis BSemantic proximity
Advances and challenges in the development and production of effective plant-based influenza vaccinesSemantic proximity
A plant-based transient expression system for the rapid production of highly immunogenic Hepatitis E virus-like particles.Semantic proximity
Plant‐made dengue virus‐like particles produced by co‐expression of structural and non‐structural proteins induce a humoral immune response in miceSemantic proximity
Insect Cell-Based Quadrivalent Seasonal Influenza Virus-like Particles Vaccine Elicits Potent Immune Responses in MiceSemantic proximity
Plant-Derived Recombinant Vaccines against Zoonotic VirusesSemantic proximity
Phase 1 trial of a Candidate Recombinant Virus-Like Particle Vaccine for Covid-19 Disease Produced in PlantsSemantic proximity
A Plant-Produced Virus-Like Particle Displaying Envelope Protein Domain III Elicits an Immune Response Against West Nile Virus in MiceSemantic proximity
Setting up a platform for plant-based influenza virus vaccine production in South AfricaSemantic proximity
Platforms, advances, and technical challenges in virus-like particles-based vaccinesSemantic proximity
Plant Viral Vectors for Vaccine DevelopmentSemantic proximity
Abanana or a syringe: journey to edible vaccinesSemantic proximity
Select a neighboring publication to make it the new centre.